Expression of PCNA in colorectal carcinoma and its clinical significance
Su Wen, UO Clinical
Abstract
Su Wen, UO Clinical
Abstract
Objective To study the expression of proliferative cell nuclear antigen(PCNA) and its clinical signiflcance in colorectal carcinoma.Methods The expression of PCNA was examined by immunohistochemical S-P methods in 54 colorectal carcinoma tissues and 14 lymph nodes with metastases.Results The positive rate of PCNA was 37.0% in colorectal carcinoma,and was 78.6% in lymph nodes with metastases (P0.05). The positive rate of PCNA was 50.0% in colorectal carcinoma tissues with lymph node metastasis,and was 32.5% in those without metastasis(P0.05).Conclusion The expression of PCNA may play a role in the development and matastasis of colorectal carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the expression of proliferative cell nuclear antigen(PCNA) and its clinical signiflcance in colorectal carcinoma.Methods The expression of PCNA was examined by immunohistochemical S-P methods in 54 colorectal carcinoma tissues and 14 lymph nodes with metastases.Results The positive rate of PCNA was 37.0% in colorectal carcinoma,and was 78.6% in lymph nodes with metastases (P0.05). The positive rate of PCNA was 50.0% in colorectal carcinoma tissues with lymph node metastasis,and was 32.5% in those without metastasis(P0.05).Conclusion The expression of PCNA may play a role in the development and matastasis of colorectal carcinoma.
Key concepts: Proliferating cell nuclear antigen, Medicine, Immunohistochemistry, Colorectal cancer, Lymph, Lymph node metastasis, Metastasis, Carcinoma